Avid Bioservices: Q2 Earnings Insights - Avid Bioservices (NASDAQ:CDMO)

Avid Bioservices CDMO reported its Q2 earnings results on Tuesday, December 7, 2021 at 04:05 PM.

Here's what investors need to know about the announcement.

Avid Bioservices beat estimated earnings by 200%, reporting an EPS of $0.06 versus an estimate of $0.02, which surprised analysts.

Revenue was up $5,045,000 from the same period last year.

Last quarter the company beat on EPS by $0.06, which was followed by a 12.05% drop in the share price the next day.

Here's a look at Avid Bioservices's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.04		-0.03	-0.06
EPS Actual	0.10	-0.04	0.01	0.01
Revenue Estimate	27.81M	21.60M	19.07M	15.49M
Revenue Actual	30.75M	27.61M	21.81M	21.06M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.